Opus Genetics (IRD) Asset Utilization Ratio (2020 - 2026)

Opus Genetics (IRD) has 7 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 36.22% year-over-year to 0.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.2 (down 36.22% YoY) and the FY2025 annual result came in at 0.33, up 34.64% from the prior year.
• Asset Utilization Ratio fell to 0.2 in Q1 2026 per IRD's latest filing, from 0.33 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.25 in Q4 2022 and bottomed at 0.03 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.35 (2023), against an average of 0.47.
• The widest annual swing landed in 2022, when Asset Utilization Ratio jumped 5145.76%; it then slumped 83.21% in 2024.
• Tracing IRD's Asset Utilization Ratio over 5 years: stood at 1.25 in 2022, then plunged by 71.9% to 0.35 in 2023, then decreased by 19.22% to 0.28 in 2024, then gained by 15.52% to 0.33 in 2025, then plunged by 37.71% to 0.2 in 2026.
• Per Business Quant, the three latest IRD Asset Utilization Ratio figures stand at 0.2 (Q1 2026), 0.33 (Q4 2025), and 0.39 (Q3 2025).

Peer Comparison